Design of novel biomolecules is the single most impactful advancement that will be enabled by AI in the coming decade. 310 is building the AI engine that delivers this reality.
| Website | http://310.ai |
| Employees | 8 (8 on RocketReach) |
| Founded | 2022 |
| Industry | Biotechnology Research |
| Keywords | Ai Drug Discovery, Precision Medicine Ai, Machine Learning Therapeutics, Innovative Drug Discovery, Computational Drug Design, Advanced Drug Delivery |
| Competitors | Zillow, Matterport, Lemonade, OpenAI, Meta, Wit.ai, NLP Cloud, Cortexica, DeepAI, Oliver Wyman +29 more (view full list) |
Looking for a particular 310 AI employee's phone or email?
Kooshiar Azimian is the Founder and CEO of 310 AI.
8 people are employed at 310 AI.
310 AI is based in San Francisco, California.